Prostate Cancer - Results from #340

Targeting AXL inhibits the growth and metastasis of prostate cancer in bone. February 7, 2025

Incisional PSMA PET/CT-positive recurrences in prostate cancer- is there an implication on clinical care? February 7, 2025

Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy. February 6, 2025

Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials. February 6, 2025

Refining partial gland ablation for localised prostate cancer: the FALCON project. February 6, 2025

Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI. February 6, 2025

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer. February 6, 2025

Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy. February 5, 2025

Repeatability, reproducibility, and the effects of radiotherapy on radiomic features of lowfield MR-LINAC images of the prostate. February 5, 2025

Key Considerations for a Prostate Cancer mRNA Vaccine. February 5, 2025

Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. February 5, 2025

Molecular Landscape of Aggressive Histologic Subtypes of Localized Prostate Cancer. February 5, 2025

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate. February 4, 2025

The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials. February 4, 2025

Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer. February 4, 2025

Testosterone replacement therapy in men on active surveillance for prostate cancer. February 4, 2025

External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. February 4, 2025

Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy. February 3, 2025

Shifting tides: A survey analysis of urologists' evolving attitudes toward focal therapy for prostate cancer. February 3, 2025

Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis. February 3, 2025

Page 18 of 1473